Renin-angiotensin-aldosterone system inhibitors and adverse outcomes of COVID-19: a Danish nationwide cohort study (ACE-I/ARB and COVID-19) First published 27/04/2020 Last updated 10/12/2020 EU PAS number:EUPAS34887 Study Finalised